Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Kassem et al., Thymosin Beta-4 (TB-500)-Ac-SDKP pathway: Any relevance for the cardiovascular system?, Can
The invention also relates to novel uses and methods of treatments using the aforementioned salts and/or compositions, in particular, with respect to the treatment of disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes, pancreatitis, hypotension and Parkinson's disease
Initial improvements from Dihexa therapy can often be noticed within several weeks of starting treatment
The synthetic peptide is often compared to naturally occurring growth factors
US$ 24.41
US$ 23.34
US$ 25.13